Wilson Ray, MD
Neurological Surgery · Saint Louis, MONPI 1669575619
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $382,750 of the $586,295 with a category attached, or 65.3%. 27 manufacturers reported payments, led by Globus Medical at 56.1% of the total. Among neurological surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 466 payments — averaging $1258.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$329K
- Medical Device Business Services, Inc.$108K
- Expanding Innovations, Inc.$55K
- Depuy Synthes Products, Inc.$32K
- Corelink, LLC$19K
- Pacira Pharmaceuticals Incorporated$11K
- plus $32K from 21 others
Across 78 payments — averaging $3341.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$112K
- Mitsubishi Tanabe Pharma Development America, Inc.$74K
- Tanabe Pharma America, Inc.$28K
- Pfizer$26K
- Cerapedics Inc.$14K
- Centinel Spine, LLC$3K
- plus $3K from 2 others
Across 6 payments — averaging $8916.48 each. An ownership or investment interest held by the physician or an immediate family member.
- Expanding Innovations, Inc.$53K
- Acera Surgical, Inc.$0
What the payments were for
- Royalty or licence$23,1274%
- Consulting fees$382,75065%
- Speaking & faculty fees$105,40018%
- Travel & lodging$61,72711%
- Food & beverage$11,1862%
- Education$1,6670%
- Entertainment$4390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 190 | $328,967 |
| Medical Device Business Services, Inc. | 80 | $107,963 |
| Expanding Innovations, Inc. | 16 | $55,149 |
| Depuy Synthes Products, Inc. | 41 | $31,680 |
| Corelink, LLC | 27 | $19,133 |
| Pacira Pharmaceuticals Incorporated | 11 | $11,012 |
| Johnson & Johnson | 15 | $10,660 |
| Orthofix Medical, Inc. | 11 | $5,091 |
| Bioventus LLC | 5 | $3,398 |
| Alphatec Spine, Inc | 4 | $3,357 |
| Medtronic(2 entities) | 31 | $3,024 |
| Medacta USA, Inc. | 10 | $2,089 |
| Carbofix Spine Inc | 1 | $1,667 |
| Zavation Medical Products, LLC | 4 | $1,465 |
| Augmedics Inc. | 3 | $394 |
| Tulavi Therapeutics, Inc. | 1 | $299 |
| Axogen | 2 | $244 |
| Integra Lifesciences Corporation | 3 | $156 |
| Aesculap Implant Systems, LLC | 1 | $140 |
| Boston Scientific | 1 | $129 |
| 4web, Inc. | 1 | $119 |
| Kuros Biosciences USA, Inc | 3 | $53 |
| VB Spine LLC | 1 | $33 |
| Viseon, Inc. | 1 | $19 |
| Centinel Spine, LLC | 1 | $19 |
| Stryker | 1 | $18 |
| Cerapedics Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPEDIUM$78,536
- Excelsius - GPS$51,718
- X-PAC$45,351
- VIPER$35,106
- ExcelsiusGPS Robotic Navigation System$31,978
- CREO$29,310
- XLIF$22,929
- SECURE-C$20,138
- CONDUIT$19,116
- CORBEL$13,433
- CREO MIS$13,343
- ALTERA$12,404
- CREO MCS, Fenestrated, Sideloading$11,616
- EXPAREL$10,531
- RISE-L$9,899
- ELSA$9,672
- RISE$7,700
- Anterior Disc Prep$6,525
- Handpiece Power System$6,300
- MISCELLANEOUS$4,802
How this compares
$586,295 in reported general payments places this provider in the 95th percentile of 172 neurological surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 76 | $3,063 |
| Mupirocin | 181 | $1,084 |
| Oxycodone Hcl | 107 | $1,019 |
| Gabapentin | 50 | $661 |
| Cyclobenzaprine Hcl | 40 | $401 |
| Methocarbamol | 26 | $257 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $173 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $95 |
| Tramadol Hcl | 22 | $78 |
| Amitriptyline Hcl | 11 | $74 |
| Tizanidine Hcl | 11 | $36 |
| Diazepam | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Saint Louis
- Neill WrightSaint Louis$1.1M
- Camilo MolinaSaint Louis$412K
- Paul SantiagoSaint Louis$368K
- Daniel ScodarySaint Louis$278K
- Daniel HafezSaint Louis$273K
- John OgunladeSaint Louis$220K
- Joshua OsbunSaint Louis$98K
- Adewale BakareSaint Louis$81K
- Eric LeuthardtSaint Louis$78K
- Nitin AgarwalSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.